Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma

Clinical trial NCT07527325 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07527325
Sponsor: University of California, Irvine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2026-07-01
Primary completion: 2029-02-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.